Prometheus Launches MyCeliacID(TM), the First Do it Yourself, Saliva-Based Genetic Test Dedicated to Celiac Disease
Posted on: Monday, 29 June 2009, 06:00 CDT
"Prometheus is a leader in celiac genetic testing, performing more than 80,000 blood-based genetic tests for celiac disease to date," said
Celiac disease appears in individuals genetically predisposed to the disease and who consume gluten, a protein found in grains such as wheat, barley and rye. MyCeliacID is the only test that provides individuals with their risk of developing the disease relative to the general population. In addition, MyCeliacID can virtually rule out celiac disease in a person's lifetime. A negative test result indicates that the individual does not have the genes associated with celiac disease and is highly unlikely to develop the disease. A positive result indicates that the individual has one or more genes that predispose to celiac disease, however it is not an indication of the disease itself. Individuals with a positive test result should see a physician, who may elect to perform other testing. Only a doctor can diagnose celiac disease.
"When my son Tyler was diagnosed in 1991, genetic testing for celiac disease wasn't available," said
MyCeliacID is available online. A licensed physician will review and place the order in accordance with state and federal law after a test request is made online. In addition, after the testing is performed, the physician will review and release the result. Test results can be accessed online via a secure link, usually within 7 days from receipt of the saliva sample.
About Celiac
Celiac disease is an immune-mediated digestive disease that is triggered by the consumption of gluten and damages the small intestine, interfering with the absorption of nutrients from food. Symptoms of celiac disease may vary significantly from person to person and include, but are not limited to, diarrhea, anemia, abdominal pain, skin rash and weight loss. The number of diagnosed patients is expected to increase significantly over the next several years, driven by broad-based educational campaigns, National Institutes of Health research funding and widely-available genetic and blood tests for highly-specific antibodies.
About Prometheus
Prometheus Laboratories Inc. is a specialty pharmaceutical and diagnostic company committed to developing and commercializing novel pharmaceutical and diagnostic products to help physicians individualize patient care. Prometheus is a leader in applying the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and intends to apply these principles to oncology. Its strategy includes the marketing and delivery of pharmaceutical products complemented by proprietary, high-value diagnostic testing services. By integrating pharmaceutical products and diagnostic testing services, Prometheus believes it can address the full continuum of care, thereby providing physicians with a comprehensive solution to treat chronic diseases. Prometheus' corporate offices are located in
SOURCE Prometheus Laboratories Inc.
Source: PR Newswire
Related Articles
- Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mineral Density
- Prometheus Awarded Patent Related to Genetic Testing for Inflammatory Bowel Disease
- Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss
- Power3 Medical Products in Talks With Industry Leaders to License and Market Its Proprietary Technology for Diagnostic, Disease Detection Blood Tests for Breast Cancer, Alzheimer's and Parkinson's Disease
- Seegene Introduces Only Diagnostic Approach Capable of Detecting Most Prevalent Sexually Transmitted Diseases in a Single Test
- Advances in Molecular Diagnostic Technologies Result in Increased Business Potential for Rapid Test Kits
- Mindreef Extends Leadership in SOA Testing and Diagnostics With Enhanced New Version of Mindreef SOAPscope; Powerful New Features Provide Advanced Testing, Diagnostics and Analysis
- Senator Drafts Genetics Bill: She Hopes Results' Privacy Would Encourage Testing
- GW Medical Technologies' New Blood Test for Alzheimer's Disease Seeks Future Test Candidates; Patients and Physicians Needed for Breakthrough Test
- Health: Am I Losing My Mind? ; Early Signs of Alzheimer's Can Now Be Detected in Middle Age. Jane Feinmann Took the Tests - and the Results Were Less Than Perfect. So What Can She Do Now?
 |
 |
User Comments (0)
RSS Feeds